World leader in marine microalgae production
Always one step ahead

R&D Projects


    The TetraFood project intends to bring into market marine microalgae-based functional foods and food supplements for the prevention of chronic diseases

    Read more



    The ALGAE4A-B project seeks to exploit the microalgae diversity, as a source for state-of-the art high-added-value biomolecules in aquaculture and cosmetics.

    Read more


  • AlgaeCom

    The AlgaeCom project seeks to exploit the convergence of science, technology, and biotechnological tools for the creation of new knowledge and innovative applications

    Read more


  • Miracles

    MIRACLES is an industry-driven R&D and innovation project aimed at developing integrated, multiple-product biorefinery technologies for the production of specialties from microalgae for application in food, aquaculture and non-food products.

    Read more


    DEGRANOS is an Innterconecta CDTI project.
    The project is about technological development for the revaluation of byproducts from the industry of cereals and pulses.

    Read more


    Study on biotechnologies with marine microalgae for diverse agro-food applications

    Read more


At Fitoplancton Marino, we believe that innovation is an essential tool for progress and differentiation.

Our commitment is reflected by our efforts and investment of millions of Euros in our R&D department. Fitoplancton Marino R&D is always focused on short-term industrial application and based on objectivity.

We have advanced along with the return on investment, without losing sight of the strong potential of microalgae and, in particular, marine microalgae.

About our projects

Our current and future projects are focused on the Agro-food, Health and Cosmetics sectors. All our projects are related to and complement each other.

One of our greatest achievements was the incorporation of the Molecular Biology and Extract Fractionation laboratories, with particular importance of the platform based on RT-qPCR. This platform allows us to develop technology to produce secondary metabolites based on genetic expression studies, allowing us to optimise production and monitor the metabolic state of cells in real time. This technology does not only allow us to improve the production process, but also guarantees the Quality Control of our production. We are also using it to study the activities in human cell lines of the different fractions obtained.